ARQT ▲ +0.6% - Arcutis Biotherapeutics, Inc.
$ARQT - Arcutis Presents New Caregiver-Reported Outcomes Data Supporting ZORYVE® (roflumilast) Cream 0.05% for Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months at the ACAAI Annual Scientific Meeting
13-NOV-2026 09:00 AM ET
Share this post
More filings for $ARQT
ARQT - Arcutis Biotherapeutics, Inc. - SEC Filing Update (10-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 10, 2026ARQT ▼ -13.0% - Arcutis Biotherapeutics, Inc.Nov 5, 2026ARQT ▼ -10.5% - Arcutis Biotherapeutics, Inc.Nov 4, 2026ARQT ▼ -7.5% - Arcutis Biotherapeutics, Inc.Nov 4, 2026ARQT ▼ -0.2% - Arcutis Biotherapeutics, Inc.Oct 28, 2026ARQT ▼ -0.4% - Arcutis Biotherapeutics, Inc.Oct 27, 2026
View full $ARQT filing history →💬 Comments
Loading comments…
Leave a comment